BRIEF-Shenzhen Salubris Pharmaceuticals’ Controlling Shareholder Plans To Sell 5% Stake To CLSA Asset Management

SAYS CONTROLLING SHAREHOLDER PLANS TO SELL 5% STAKE IN THE COMPANY TO CLSA ASSET MANAGEMENT LIMITED FOR 1.78 BILLION YUAN ($260.85 million) Source text in Chinese: bit.ly/2ESKeFq Further company …
( read original story …)